Home
SPRY
SPRY News

Latest ARS Pharmaceuticals Inc. (SPRY) News on July 26, 2024

US Growth Companies With Insider Ownership As High As 31%

Simply Wall St.

2 days ago

US Growth Companies With Insider Ownership As High As 31%

MT Newswires

a month ago

ARS Pharmaceuticals' Adrenaline Nasal Spray Receives EMA Committee's Positive Opinion

GlobeNewswire

a month ago

ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)

US Growth Companies With High Insider Ownership To Watch

Simply Wall St.

a month ago

US Growth Companies With High Insider Ownership To Watch

Owning 30% shares,institutional owners seem interested in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY),

Simply Wall St.

a month ago

Owning 30% shares,institutional owners seem interested in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY),

Top US Growth Companies With High Insider Ownership To Watch In May 2024

Simply Wall St.

2 months ago

Top US Growth Companies With High Insider Ownership To Watch In May 2024

GuruFocus.com

2 months ago

ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns with EPS Projections Amidst Regulatory ...

ARS Pharmaceuticals First Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.16 loss in 1Q 2023)

Simply Wall St.

3 months ago

ARS Pharmaceuticals First Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.16 loss in 1Q 2023)

GlobeNewswire

3 months ago

ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

Barrons.com

4 months ago

ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

GlobeNewswire

4 months ago

ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)

Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation

Simply Wall St.

4 months ago

Here's Why We're Not Too Worried About ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation

ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's What You Should Know

Zacks

4 months ago

ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's What You Should Know

Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why

Zacks

4 months ago

Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why

GuruFocus.com

4 months ago

ARS Pharmaceuticals Inc (SPRY) Reports Full Year and Q4 2023 Financial Results

GlobeNewswire

4 months ago

ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

5 months ago

ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day

GlobeNewswire

5 months ago

ARS Pharmaceuticals to Participate in the Leerink Partners Global Biopharma Conference 2024

ARS Pharmaceuticals announces neffy® meets primary endpoints and shows rapid symptom control in Phase 2 urticaria clinical study

GlobeNewswire

5 months ago

ARS Pharmaceuticals announces neffy® meets primary endpoints and shows rapid symptom control in Phase 2 urticaria clinical study

GlobeNewswire

5 months ago

ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024

Loss-Making ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Expected To Breakeven In The Medium-Term

Simply Wall St.

5 months ago

Loss-Making ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Expected To Breakeven In The Medium-Term

ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA’s Complete Response Letter

GlobeNewswire

5 months ago

ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA’s Complete Response Letter

GlobeNewswire

6 months ago

ARS Pharmaceuticals to Present Positive Clinical Efficacy Data for neffy® (epinephrine nasal spray) at 2024 AAAAI Annual Meeting

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Pitney Bowes Inc Earnings Call

KKR Real Estate Finance Trust Inc. Tax Treatment of 2023 Dividends

Business Wire

6 months ago

KKR Real Estate Finance Trust Inc. Tax Treatment of 2023 Dividends

Unum (UNM) Q4 Earnings Miss Estimates

Zacks

6 months ago

Unum (UNM) Q4 Earnings Miss Estimates

Business Wire

6 months ago

Hope Bancorp Declares Quarterly Cash Dividend of $0.14 Per Share

Strength Seen in GigaCloud Technology Inc. (GCT): Can Its 10.0% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in GigaCloud Technology Inc. (GCT): Can Its 10.0% Jump Turn into More Strength?

Provident Financial Services Inc Reports Mixed Results Amid Economic Challenges

GuruFocus.com

6 months ago

Provident Financial Services Inc Reports Mixed Results Amid Economic Challenges

Here is What to Know Beyond Why Energy Fuels Inc (UUUU) is a Trending Stock

Zacks

6 months ago

Here is What to Know Beyond Why Energy Fuels Inc (UUUU) is a Trending Stock

GlobeNewswire

6 months ago

Magnite to Announce Fourth Quarter 2023 Financial Results on February 28, 2024

Core Laboratories (CLB) Reports Next Week: What You Should Expect

Zacks

6 months ago

Core Laboratories (CLB) Reports Next Week: What You Should Expect

Carlyle Secured Lending, Inc. Schedules Fourth Quarter and Full Year 2023 Financial Results and Investor Conference Call

GlobeNewswire

6 months ago

Carlyle Secured Lending, Inc. Schedules Fourth Quarter and Full Year 2023 Financial Results and Investor Conference Call

Beverages and Alcohol Stocks Q3 Recap: Benchmarking PepsiCo (NASDAQ:PEP)

StockStory

6 months ago

Beverages and Alcohol Stocks Q3 Recap: Benchmarking PepsiCo (NASDAQ:PEP)

Title Resources Group Welcomes New Executive

PR Newswire

6 months ago

Title Resources Group Welcomes New Executive

18 Most Profitable Value Stocks Now

Insider Monkey

6 months ago

18 Most Profitable Value Stocks Now

Kura Sushi Must Live Up to High Hopes After Wowing Wall Street

Bloomberg

6 months ago

Kura Sushi Must Live Up to High Hopes After Wowing Wall Street

Herbalife Wins Two Gold Excellence Awards for Providing Best-In-Class Education and Tools to Help Its Independent Distributors Grow Their Businesses

Business Wire

6 months ago

Herbalife Wins Two Gold Excellence Awards for Providing Best-In-Class Education and Tools to Help Its Independent Distributors Grow Their Businesses

What European Wax Center, Inc.'s (NASDAQ:EWCZ) ROE Can Tell Us

Simply Wall St.

7 months ago

What European Wax Center, Inc.'s (NASDAQ:EWCZ) ROE Can Tell Us

European Wax Center, Inc. Provides Update Ahead of Presentation at ICR Conference 2024

GlobeNewswire

7 months ago

European Wax Center, Inc. Provides Update Ahead of Presentation at ICR Conference 2024

Asia wealth managers flock to Dubai as clients look to diversify

Reuters

7 months ago

Asia wealth managers flock to Dubai as clients look to diversify

Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

Zacks

7 months ago

Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

The Returns At Marten Transport (NASDAQ:MRTN) Aren't Growing

Simply Wall St.

7 months ago

The Returns At Marten Transport (NASDAQ:MRTN) Aren't Growing

Golden Entertainment Inc CFO Charles Protell Sells 35,946 Shares

GuruFocus.com

7 months ago

Golden Entertainment Inc CFO Charles Protell Sells 35,946 Shares

AMC Networks Inc EVP and General Counsel James Gallagher Sells 22,000 Shares

GuruFocus.com

7 months ago

AMC Networks Inc EVP and General Counsel James Gallagher Sells 22,000 Shares

4 Low Price-to-Book Stocks to Buy in the New Year

Zacks

7 months ago

4 Low Price-to-Book Stocks to Buy in the New Year

Archer Daniels (ADM) to Acquire FDL, To Expand Flavor Business

Zacks

7 months ago

Archer Daniels (ADM) to Acquire FDL, To Expand Flavor Business

Sinking Natural Gas Prices Aren't Stopping The IBD Stock Of The Day From Nearing Buy Point

Investor's Business Daily

7 months ago

Sinking Natural Gas Prices Aren't Stopping The IBD Stock Of The Day From Nearing Buy Point

The Hanover Insurance Group, Inc. to Issue Fourth Quarter Financial Results on January 31

PR Newswire

7 months ago

The Hanover Insurance Group, Inc. to Issue Fourth Quarter Financial Results on January 31

Business Wire

7 months ago

Paramount Declares Regular Quarterly Dividend

12 Best Healthcare Stocks For the Long-Term

Insider Monkey

8 months ago

12 Best Healthcare Stocks For the Long-Term

Methode Electronics, Inc. Reports Fiscal 2024 Second Quarter Financial Results

GlobeNewswire

8 months ago

Methode Electronics, Inc. Reports Fiscal 2024 Second Quarter Financial Results

The Buckle, Inc. Announces a $2.50 Per Share Special Cash Dividend, a $0.35 Per Share Quarterly Dividend, and Leadership Appointments

Business Wire

8 months ago

The Buckle, Inc. Announces a $2.50 Per Share Special Cash Dividend, a $0.35 Per Share Quarterly Dividend, and Leadership Appointments

Investors in Varex Imaging (NASDAQ:VREX) have unfortunately lost 22% over the last five years

Simply Wall St.

8 months ago

Investors in Varex Imaging (NASDAQ:VREX) have unfortunately lost 22% over the last five years

BofA Securities Downgraded These 3 Office REITs

Benzinga

8 months ago

BofA Securities Downgraded These 3 Office REITs

Docebo Inc.'s (TSE:DCBO) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Simply Wall St.

8 months ago

Docebo Inc.'s (TSE:DCBO) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Business Wire

8 months ago

Get It Now! Opens Store in Rhinelander, Wisconsin

GlobeNewswire

9 months ago

ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates

Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Xencor, Inc. (NASDAQ:XNCR) Q3 2023 Earnings Call Transcript

GlobeNewswire

9 months ago

ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis

Karooooo Ltd. (NASDAQ:KARO) Shares Could Be 30% Below Their Intrinsic Value Estimate

Simply Wall St.

9 months ago

Karooooo Ltd. (NASDAQ:KARO) Shares Could Be 30% Below Their Intrinsic Value Estimate

Share on Social Networks: